华盛顿特区讯 — 根据最新提交给美国证券交易委员会的文件显示，Vanda制药公司（NASDAQ:VNDA）总裁兼首席执行官Mihael Hristos Polymeropoulos于2月25日以加权平均价格4.464美元购入了10,000股公司普通股 ...

YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from ...